Evercore ISI says three years of biotech underperformance may be ending. Gives its 5 favorite stocks
Evercore initiated coverage on the biotech sector and named its seven favorite stocks it calls "The Magnificent Seven." Source link
Read MoreEvercore initiated coverage on the biotech sector and named its seven favorite stocks it calls "The Magnificent Seven." Source link
Read MoreTwo recent M&A announcements by big pharma are creating excitement among investors. Here's who is poised to benefit. Source link
Read MoreSee which stocks are posting big moves after the bell. Source link
Read More"Big BioPharma needs growth," says Wells Fargo analyst Mohit Bansal in a research note that anticipates a pick-up in smaller
Read MoreAmid the market turmoil, a growing number of biotech stocks are now trading below the value of the cash on
Read More